Nox Peptides expands BPC-157 and GHK-Cu research focus in Canada
The company says the broadened program centres on two of the most closely watched gray-market recovery and skin peptides.
TR
By Tom Reyes · Markets Editor
Oct 1 08:57 ETSource: Yahoo Finance
The wire
- 01Nox Peptides announced an expanded research focus on BPC-157 and GHK-Cu in Canada, according to a company statement distributed through Yahoo Finance.
- 02Both peptides sit at the centre of the research-chemical supply question, so any commercial program around them draws scrutiny from regulators and clinicians.
- 03The announcement is a company release with no study design, endpoints or regulatory filings disclosed.
From the source
Read at finance.yahoo.comNox Peptides Announces Expanded Research Focus on BPC-157 and GHK-Cu in Canada
